COVID-19 pneumonia. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group: Patients receive Noscapine Syrup (Noscough®) 20 cc every 6 hours for 5 days. Intervention 2: Control group: Patients receive 7 cc diphenhydramine every 8 hours.
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: People over 18 years old Patient with cough and positive RT-PCR for COVID-19 and candidate for outpatient treatment The onset of illness equal to/less than 5 days
Exclusion criteria
Exclusion criteria: Pregnancy Breastfeeding Allergy to noscapine, morphine or any of the components of the formulation History of seizure Diarrhea Diabetes Consumption of warfarin, benzodiazepines, opioid agonists Getting antitussive drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time required to respond to treatment. Timepoint: Daily until discharge. Method of measurement: VAS scale.;Time required to resolve cough. Timepoint: Daily until discharge. Method of measurement: Patient history.;Intensity of cough. Timepoint: Daily until discharge. Method of measurement: CSS score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life. Timepoint: Before the start of the study and at the end of the study. Method of measurement: CQLQ questionnaire.;Blood oxygen level. Timepoint: Before the start of the study and at the end of the study. Method of measurement: Pulse oximeter.;Shortness of breath. Timepoint: Before the start of the study and at the end of the study. Method of measurement: Patient history. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSahar Yousefian
Shahid Beheshti University of Medical Sciences
Outcome results
None listed